PDF(1308 KB)
Factors influencing the prognosis of patent ductus arteriosus in very low birth weight infants
WANG Chen-Hong, SHI Li-Ping, MA Xiao-Lu, LUO Fang, CHEN Zheng, LIN Hui-Jia, DU Li-Zhong
Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (8) : 688-693.
PDF(1308 KB)
PDF(1308 KB)
Factors influencing the prognosis of patent ductus arteriosus in very low birth weight infants
Objective To investigate the factors influencing the prognosis of patent ductus arteriosus (PDA) in very low birth weight (VLBW) infants. Methods A total of 194 VLBW infants who were admitted from January 2012 to December 2014 were enrolled as study subjects. According to cardiac ultrasound findings and treatment outcome, these infants were divided into non-PDA group, spontaneous closure group, pharmaceutical closure group, and surgical closure group. Their clinical and echocardiographic characteristics were analyzed. Results The spontaneous closure rate of PDA was 58.7%. The spontaneous closure group showed significantly higher gestational age, birth weight, and proportion of small-for-gestational-age infants than the pharmaceutical and surgical closure groups (P < 0.05). The pharmaceutical and surgical closure groups had a significantly higher incidence rate of neonatal respiratory distress syndrome and a significantly higher proportion of infants who were given pulmonary surfactant (PS) than the spontaneous closure group (P < 0.05). During different periods of time, the spontaneous closure group had a significantly smaller ductus arteriosus diameter than the pharmaceutical and surgical closure groups (P < 0.05). The multivariate logistic regression analysis showed that gestational age, application of PS, and ductus arteriosus diameter at 48 hours were significantly associated with the prognosis of PDA. The major transductal flow pattern in the spontaneous closure group was closing pattern, while in the pharmaceutical and surgical closure groups, the main flow patterns were pulmonary hypertension and growing patterns within 48 hours and growing pattern on days 4 and 7. Conclusions The VLBW infants have a high spontaneous closure rate of PDA. A decreased closure rate of PDA is associated with the lower gestational age and the application of PS. PDA with a large ductus arteriosus diameter and a growing or pulsatile flow pattern cannot easily achieve spontaneous closure.
Patent ductus arteriosus / Pharmacotherapy / Ligation of patent ductus arteriosus / Echocardiography / Very low birth weight infant
[1] Abdel-Hady H,Nasef N,Shabaan AE,et al.Patent ductus arteriosus in preterm infants:do we have the right answers?[J]Biomed Res Int,2013,2013:676192.
[2] Evans N.Preterm patent ductus arteriosus:should we treat it?[J]J Paediatr Child Health,2012,48(9):753-758.
[3] Chiruvolu A,Jaleel MA.Therapeutic management of patent ductus arteriosus[J].Early Hum Dev,2009,85(3):151-155.
[4] Koch J,Hensley G,Roy L,et al.Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less[J].Pediatrics,2006,117(4):1113-1121.
[5] Tavera MC,Bassareo PP,Biddau R,et al.Role of echocardiography on the evaluation of patent ductus arteriosus in newborns[J].J Matern Fetal Neonatal Med,2009,22 Suppl 3:10-13.
[6] De Buyst J,Rakza T,Pennaforte T,et al.Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus[J].J Pediatr,2012,161(3):404-408.
[7] Visconti LF,Morhy SS,Deutsch AD,et al.Clinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g[J].Einstein (Sao Paulo),2013,11(3):317-323.
[8] Sellmer A,Bjerre JV,Schmidt MR,et al.Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3[J].Arch Dis Child Fetal Neonatal Ed,2013,98(6):F505-F510.
[9] Evans N.Preterm patent ductus arteriosus:A continuing conundrum for the neonatologist?[J]Semin Fetal Neonatal Med,2015,20(4):272-277.
[10] Schmidt B,Davis P,Moddemann D,et al.Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants[J].N Engl J Med,2001,344(26):1966-1972.
[11] Schmidt B,Roberts RS,Fanaroff A,et al.Indomethacin prophylaxis,patent ductus arteriosus,and the risk of bronchopulmonary dysplasia:further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP)[J].J Pediatr,2006,148(6):730-734.
[12] Noori S,Friedlich P,Seri I,et al.Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants[J].J Pediatr,2007,150(6):597-602.
[13] McNamara PJ,Stewart L,Shivananda SP,et al.Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g[J].J Thorac Cardiovasc Surg,2010,140(1):150-157.
[14] Kabra NS,Schmidt B,Roberts RS,et al.Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants:results from the Trial of Indomethacin Prophylaxis in Preterms[J].J Pediatr,2007,150(3):229-234.
[15] Rolland A,Shankar-Aguilera S,Diomandé D,et al.Natural evolution of patent ductus arteriosus in the extremely preterm infant[J].Arch Dis Child Fetal Neonatal Ed,2015,100(1):F55-F58.
[16] Herrman K,Bose C,Lewis K,et al.Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit[J].Arch Dis Child Fetal Neonatal Ed,2009,94(1):F48-F50.
[17] Nemerofsky SL,Parravicini E,Bateman D,et al.The ductus arteriosus rarely requires treatment in infants >1000 grams[J].Am J Perinatol,2008,25(10):661-666.
[18] 杜金凤,刘田田,武辉.早期早产儿动脉导管未闭发生的危险因素的病例对照研究[J].中国当代儿科杂志,2016,18(1):15-19.
[19] McPherson C,Gal P,Ransom JL,et al.Indomethacin pharmacodynamics are altered by surfactant:a possible challenge to current indomethacin dosing guidelines created before surfactant availability[J].Pediatr Cardiol,2010,31(4):505-510.
[20] El Hajjar M,Vaksmann G,Rakza T,et al.Severity of the ductal shunt:a comparison of different markers[J].Arch Dis Child Fetal Neonatal Ed,2005,90(5):F419-F422.
[21] McNamara PJ,Sehgal A.Towards rational management of the patent ductus arteriosus:the need for disease staging[J].Arch Dis Child Fetal Neonatal Ed,2007,92(6):F424-F427.
[22] Su BH,Watanabe T,Shimizu M,et al.Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants[J].Arch Dis Child Fetal Neonatal Ed,1997,77(1):F36-F40.
